Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  duvelisib
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
A Phase 3 Extension Study of Duvelisib and Ofatumumab in Patients With CLL/SLL Previously Enrolled in Study IPI-145-07
Status: Enrolling by invitation
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: IPI-145-12, NCI-2014-02041, NCT02049515
PI3K Delta/Gamma Inhibitor IPI-145 and Romidepsin or Bortezomib in Treating Patients with Relapsed or Refractory T-cell Lymphoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 16-042, NCI-2016-00894, NCT02783625
Start Over